News
Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...
England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.
Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear ...
Moximed has announced the treatment of the first subject in the MOTION randomised controlled trial (RCT) assessing its MISHA ...
Helix has released a new suite of pharmacogenomics (PGx) tests, widening its portfolio in neurology and oncology.
HistoSonics' Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet ...
The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...
BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...
The FDA has granted 510(k) clearance for Distalmotion’s DEXTER robotic surgery system to be used in adult cholecystectomies.
NeuroPace has reported the initial primary endpoint one-year outcomes from the NAUTILUS trial of the RNS System.
The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...
Danish medtech Brainreader has secured $7.3m (€6.6m) to support the market rollout of Neuroreader, its artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results